Dr Andrea Wilson of Edith Cowan University and the DCRC – Early Diagnosis and Prevention has completed a literature review of the use of biomarkers for Alzheimer's disease.
The very interesting findings from the research include:
- The use of using CSF biomarkers in AD risk reduction, diagnosis and research is more important than ever
- There are risks associated with the collection of CSF However, it has been found that clinical quality control measures can mitigate these risks
- This research has implications for future research and knowledge translation
Andrea’s comprehensive report written non-technically for Dementia Research News is available here: “Cerebral Spinal Fluid Biomarkers for use in Alzheimer’s Disease Research Collection"
Other stories from this edition of Dementia Research News:
News in brief: